Current Search:  Research Repository (x) » Citation (x) » Shukla, P. (x) » design (x) » Blaber, Michael (x)

Search results

  • CSV Spreadsheet
(1 - 50 of 61)

Pages

Accelerated healing in NONcNZO10/LtJ type 2 diabetic mice by FGF 1
Activation Profiles of Human Kallikrein-Related Peptidases by Matrix          Metalloproteinases
Activation Profiles of Human Kallikrein-Related Peptidases by Proteases of the          Thrombostasis Axis
Alternative Folding Nuclei Definitions Facilitate the Evolution of a Symmetric Protein Fold from a Smaller Peptide Motif
Autolytic Regulation of Human Kallikrein-Related Peptidase 6
Completed KLK Activome Profile
Crystal Structure and Biochemical Characterization of Human Kallikrein 6 Reveals a Trypsin-like Kallikrein is Expressed in the Central Nervous System
Emergence of Symmetric Protein Architecture from a Simple Peptide Motif
Engineered human acidic fibroblast growth factors and associated methods
Engineering a Cysteine-Free Form of Human Fibroblast Growth Factor-1 for "2nd Generation" Therapeutic Application
Engineering a Cysteine-Free Form of Human Fibroblast Growth Factor-1 for "Second Generation" Therapeutic Application.
Engineering an Improved Crystal Contact Across a Solvent-Mediated Interface of Human          Fibroblast Growth Factor 1
Evolution and design of protein structure by folding nucleus symmetric expansion
Evolution of a Protein Folding Nucleus
Experimental Support for the Evolution of Symmetric Protein Architecture from a Simple          Peptide Motif
Experimental support for the foldability-function tradeoff hypothesis
Expression and Function of the Kallikrein-Related Peptidase 6 in the Human Melanoma          Microenvironment
Fibroblast growth factor mutants having improved functional half-life and methods of their use
Fibroblast growth factor mutants having improved functional half-life and methods of their use
Fibroblast growth factor mutants having improved functional half-life and methods of their use
Fine-sampled Photographic Quantitation of Dermal Wound Healing Senescence in Aged BALB/cByJ Mice and Therapeutic Intervention with FGF-1
Folding Nucleus Structure Persists in Thermally-Aggregated FGF-1
Functional Intersection of the Kallikrein-Related Peptidases (KLKs) and Thrombostasis          Axis
Functional Role of Kallikrein 6 in Regulating Immune Cell Survival
insight into the thermodynamic characteristics of human thrombopoietin complexation with TN1 antibody.
Investigating the Dynamics and Polyanion Binding Sites of Fibroblast Growth Factor-1 Using Hydrogen-Deuterium Exchange Mass Spectrometry
Isomannide-based peptidomimetics as inhibitors for human tissue kallikreins 5 and 7.
Kallikrein 6 is a Novel Molecular Trigger of Reactive Astrogliosis
Kallikrein 6 Signals through PAR1 and PAR2 to Promote Neuron Injury and Exacerbate Glutamate Neurotoxicity
Kallikrein cascades in traumatic spinal cord injury
Kallikrein-related Peptidase 6
Kallikreins are Associated with Secondary Progressive Multiple Sclerosis and Promote          Neurodegeneration
Mathematical Model for the Determination of Mouse Excisional Wound Healing Parameters from Photographic Data
Method for Development of a Peptide Building Block Useful for De Novo Protein Design_B2
Method of treating multiple sclerosis with anti-K6 antibody
Molecular Modeling of Substrate Binding in Wild-type and Mutant Corynebacteria 2,5-diketo-D-gluconate Reductases
Mutagenesis of the Crystal Contact of Acidic Fibroblast Growth Factor
Mutant polypeptides of fibroblast growth factor 1
Mutant polypeptides of fibroblast growth factor 1
Mutant polypeptides of fibroblast growth factor 1
Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency
Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency
Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency
Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency
Mutation Choice to Eliminate Buried Free Cysteines in Protein Therapeutics
Myths and Verities in Protein Folding Theories
Pharmacokinetic Properties of 2(nd)-Generation Fibroblast Growth Factor-1 Mutants for          Therapeutic Application
Pharmacokinetic properties of 2nd-generation fibroblast growth factor-1 mutants for therapeutic application.
Prebiotic Protein Design supports a Halophile Origin of Foldable Proteins
Protease-Activated Receptor Dependent and Independent Signaling by Kallikreins 1 and 6          in CNS Neuron and Astroglial Cell Lines

Pages